A new coronavirus vaccine heading to India was developed by a small team in Texas. It expects nothing in return.
The ambition is to create a low-cost, open-source alternative to expensive and limited supply mRNA vaccines for developing and under-vaccinated countries.
Continue Reading https://www.washingtonpost.com
Join the Discussion